- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07734818
Development and Validation of Mobile Application for Upper Limb Function in Stroke Survivors
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Haziqa Pari, MSNMPT
- Phone Number: +923044516865
- Email: haziqamalik44@gmail.com
Study Contact Backup
- Name: Aruba Saeed, Supervisor
- Phone Number: +92 334 4399403
- Email: aruba.saeed@ubas.edu.pk
Study Locations
-
-
Punjab Province
-
Lahore, Punjab Province, Pakistan
- Lahore University of Biological and Applied Sciences
-
Contact:
- Aruba Saeed, PhD
- Phone Number: 0334 4399403
- Email: arubasaeedpt@gmail.com
-
Lahore, Punjab Province, Pakistan, 54000
- Services Hospital
-
Contact:
- Aruba Saeed, Phd
- Phone Number: 0334 4399403
- Email: arubaseed@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Subacute and chronic stroke patient > 3 months post stroke. Modified Ashworth scale <3 MOCA > 24. An ability to understand the command First ever stroke Grade II, III, IV on Functional mobility Scale Able to use and comprehend smart phone.
Exclusion Criteria:
Posterior circulation stroke. Vestibular disorders, paroxysmal vertigo Presence of other neurological conditions such as neglect, hemianopsia and pushing syndrome Presence of orthopedic diseases involving the upper limb
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Clinical Exercise group
Participants in the Clinical Exercise-Based Group will receive standard physiotherapy in a clinical setting, including range-of-motion, strengthening, task-specific functional, and repetitive motor exercises for the affected upper limb.
Sessions will be conducted 3 times per week for 45 minutes over 8 weeks following standardized clinical protocols.
|
Range-of-Motion Exercises: Include passive, active-assisted, and active movements of the shoulder, elbow, wrist, and fingers along with stretching to maintain joint mobility and reduce stiffness. Strengthening Exercises: Involve resisted upper limb exercises using TheraBands, weights, and therapy tools to improve shoulder, elbow, forearm, wrist, and hand strength, including grip and pinch strengthening. Task-Specific Functional Activities: Focus on functional and daily-life tasks such as reaching, grasping, object manipulation, pegboard tasks, ADL simulations, fine motor activities, and repetitive bilateral upper-limb training to enhance coordination and motor recovery. |
|
Experimental: m Health
Participants receive upper limb rehabilitation via a mobile app with structured exercises for range of motion, strengthening, and functional tasks targeting the shoulder, elbow, wrist, and hand to improve motor control and coordination.
Sessions last 45 minutes, 3 times weekly for 8 weeks.
|
Progressive Training Plan (8 Weeks) Phase I (Weeks 1-4): ROM & Early Activation:
Phase II (Weeks 5-8): Strengthening & Functional Training:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Wolf Motor Function Test
Time Frame: The assesment will be done at baseline and after completion of 8 weeks.
|
The Wolf Motor Function Test (WMFT) is a standardized tool for assessing upper limb motor function in stroke survivors (Wolf et al., 2001).
It includes 17 tasks: 15 timed functional activities (e.g., lifting objects, stacking) and 2 strength measures (grip and pinch).
It evaluates movement speed, function, and quality, with performance rated on a 6-point scale (0-5) and faster times indicating better ability.
The WMFT has high reliability (ICC > 0.90) and strong validity, correlating well with FMA and ARAT.
|
The assesment will be done at baseline and after completion of 8 weeks.
|
|
Fugl-Meyer Assessment - Upper Extremity
Time Frame: The assesment will be done at baseline and after completion of 8 weeks.
|
The Fugl-Meyer Assessment (FMA) is a widely used tool to measure motor impairment after stroke (Fugl-Meyer et al., 1975).
It evaluates upper limb function including reflexes, coordination, and voluntary movement of the shoulder, elbow, wrist, and hand.
The total score ranges up to 66, with higher scores indicating better motor recovery.
Each item is scored from 0 to 2, and the sum reflects overall performance.
It has excellent reliability (ICC > 0.95) and strong validity for tracking motor recovery over time.
|
The assesment will be done at baseline and after completion of 8 weeks.
|
|
Nine Hole Peg Test
Time Frame: The assesment will be done at baseline and after completion of 8 weeks.
|
The Nine-Hole Peg Test (NHPT) is a standardized, timed assessment used to measure fine motor dexterity of the upper limb (Mathiowetz et al., 1985).
Participants place and remove nine pegs from a pegboard as quickly as possible, and performance is recorded in seconds.
Lower completion time indicates better dexterity.
It shows high reliability (ICC 0.88-0.99)
and strong validity in stroke and other neurological conditions.
|
The assesment will be done at baseline and after completion of 8 weeks.
|
Collaborators and Investigators
Publications and helpful links
General Publications
- Malik AN, Afridi A, Rathore FA. Mobile Health (mHealth) Applications for Stroke Rehabilitation: A mini review. J Pak Med Assoc. 2024 Sep;74(9):1723-1726. doi: 10.47391/JPMA.24-74.
- Cao W, Li A, Kadir AA, Chen J, Chen L, Li Q, Hassan II. Older adult stroke survivors' needs and perspectives of a stroke app: a qualitative study. BMC Geriatr. 2025 Mar 29;25(1):212. doi: 10.1186/s12877-025-05849-1.
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- UBAS/ERB/26/04/036 Haziqa
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.